The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment-Elevation Acute Coronary Syndromes
Open accessAbstract
Background Diabetes mellitus is a major risk factor for adverse outcomes after acute coronary syndromes (ACS). Because this disease may be associated with increased platelet aggregation, we investigated whether diabetic patients with ACS derive particular benefit from platelet glycoprotein (GP) IIb/IIIa receptor inhibition. Methods and Results We performed a meta-analysis of the diabetic populations enrolled in the 6 large-scale platelet GP IIb/IIIa inhibitor ACS trials: PRISM, PRISM-PLUS, PARAGON A, PARAGON B, PURSUIT, and GUSTO IV. Among 6458 diabetic patients, platelet GP IIb/IIIa inhibition was associated with a significant mortality reduction at 30 days, from 6.2% to 4.6% (OR 0.74; 95% CI 0.59 to 0.92; P =0.007). Conversely, 23 072 nondiabetic patients had no survival benefit (3.0% versus 3.0%). The interaction between platelet GP IIb/IIIa inhibition and diabetic status was statistically significant ( P =0.036). Among 1279 diabetic patients undergoing percutaneous coronary intervention (PCI) during index hospitalization, the use of these agents was associated with a mortality reduction at 30 days from 4.0% to 1.2% (OR 0.30; 95% CI 0.14 to 0.69; P =0.002). Conclusions This meta-analysis, including the entire large-scale trial experience of intravenous platelet GP IIb/IIIa inhibitors for the medical management of non–ST-segment-elevation ACS, shows that these agents may significantly reduce mortality at 30 days in diabetic patients. Although not based on a randomized assessment, the survival benefit appears to be of greater magnitude in patients undergoing PCI. Therefore, the use of platelet GP IIb/IIIa inhibitors should be strongly considered in diabetic patients with ACS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
King, H., Aubert, R. E., & Herman, W. H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1414 · Cited by 6,311
Lewis, H. D., Davis, J. W., Archibald, D. G., Steinke, W. E., Smitherman, T. C., Doherty, J. E., Schnaper, H. W., LeWinter, M. M., Linares, E., Pouget, J. M., et al. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090703 · Cited by 1,709
(1998) · New England Journal of Medicine · doi:10.1056/nejm199808133390704 · Cited by 1,432
(1998) · New England Journal of Medicine · doi:10.1056/nejm199805213382102 · Cited by 1,321
Aspirin, Sulfinpyrazone, or Both in Unstable Angina: Results of a Canadian Multicenter Trial
Cairns, J. A., Gent, M., Singer, J., Finnie, K. J., Froggatt, G. M., Holder, D. A., Jablonsky, G., Kostuk, W. J., Melendez, L. J., Myers, M. G., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511283132201 · Cited by 1,120
Diabetes and atherosclerosis: An epidemiologic view
Pyörälä, K., Laakso, M., & Uusitupa, M. (1987) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610030206 · Cited by 919
A Comparison of Aspirin plus Tirofiban with Aspirin plus Heparin for Unstable Angina
(1998) · New England Journal of Medicine · doi:10.1056/nejm199805213382103 · Cited by 796
Malmberg, K., Yusuf, S., Gerstein, H. C., Brown, J., Zhao, F., Hunt, D., Piegas, L., Calvin, J., Keltai, M., Budaj, A., et al. (2000) · Circulation · doi:10.1161/01.cir.102.9.1014 · Cited by 750
Heeschen, C., Hamm, C. W., Goldmann, B., Deu, A., Langenbrink, L., & White, H. D. (1999) · The Lancet · doi:10.1016/s0140-6736(99)10285-x · Cited by 512
Self-citationMcCance, D. R., Dyer, D. G., Dunn, J. A., Bailie, K. E., Thorpe, S. R., Baynes, J. W., & Lyons, T. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116482 · Cited by 444
Mak, K.-H., Moliterno, D. J., Granger, C. B., Miller, D. P., White, H. D., Wilcox, R. G., Califf, R. M., & Topol, E. J. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00118-6 · Cited by 430
Self-citationGeorge Lyman Duff Memorial Lecture. Atherogenesis in diabetes.
Bierman, E. L. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.6.647 · Cited by 413
Abciximab reduces mortality in diabetics following percutaneous coronary intervention
Bhatt, D. L., Marso, S. P., Lincoff, A. M., Wolski, K. E., Ellis, S. G., & Topol, E. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00650-6 · Cited by 336
Self-citationTopol, E. J., Mark, D. B., Lincoff, A. M., Cohen, E., Burton, J., Kleiman, N., Talley, D., Sapp, S., Booth, J., Cabot, C. F., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)10018-7 · Cited by 324
Self-citationGranger, C. B., Califf, R. M., Young, S., Candela, R., Samara, J., Worley, S., Kereiakes, D. J., & Topol, E. J. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90348-5 · Cited by 292
Self-citationDavı̀, G., Gresele, P., Violi, F., Basili, S., Catalano, M., Giammarresi, C., Volpato, R., Nenci, G. G., Ciabattoni, G., & Patrono, C. (1997) · Circulation · doi:10.1161/01.cir.96.1.69 · Cited by 223
Evidence for abnormal platelet glycoprotein expression in diabetes mellitus
TSCHOEPE, D., ROESEN, P., KAUFMANN, L., SCHAUSEIL, S., KEHREL, B., OSTERMANN, H., & GRIES, F. A. (1990) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1990.tb02264.x · Cited by 217
Calles-Escandón, J., Mirza, S. A., Sobel, B. E., & Schneider, D. J. (1998) · Diabetes · doi:10.2337/diab.47.2.290 · Cited by 147
Elevated Circulating P-Selectin in Insulin Dependent Diabetes Mellitus
Jilma, B., Fasching, P., Ruthner, C., Rumplmayr, A., Ruzicka, S., Kapiotis, S., Wagner, O. F., & Eichler, H. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650578 · Cited by 111
Shear-Induced Platelet Adhesion and Aggregation on Subendothelium Are Increased in Diabetic Patients
Knobler, H., Savion, N., Shenkman, B., Kotev‐Emeth, S., & Varon, D. (1998) · Thrombosis Research · doi:10.1016/s0049-3848(98)00050-4 · Cited by 108
Théroux, P., Alexander, J., Pharand, C., Barr, E., Snapinn, S. M., Ghannam, A. F., & Sax, F. L. (2000) · Circulation · doi:10.1161/01.cir.102.20.2466 · Cited by 85
Platelet-Leukocyte-Cross-Talk in Diabetes Mellitus
Tschoepe, D., Rauch, U., & Schwippert, B. (1997) · Hormone and Metabolic Research · doi:10.1055/s-2007-979115 · Cited by 76
Increased Aggregation of Human Platelets Produced by Advanced Glycation End Productsin Vitro
Hangaishi, M., Taguchi, J., Miyata, T., Ikari, Y., Togo, M., Hashimoto, Y., Watanabe, T., Kimura, S., Kurokawa, K., & Ohno, M. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8945 · Cited by 54
Hypersensitivity of diabetic human platelets to platelet activating factor
Shukla, S. D., Paul, A., & Klachko, D. M. (1992) · Thrombosis Research · doi:10.1016/0049-3848(92)90194-f · Cited by 43
Cited by
Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261
Self-citation2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.017 · Cited by 3,595
Self-citationWriting Committee Members, Levine, G. N., Bates, E. R., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31823ba622 · Cited by 3,289
Self-citationAuthors/Task Force Members, Hamm, C. W., Bassand, J.-P., Agewall, S., Bax, J., Boersma, E., Bueno, H., Caso, P., Dudek, D., Gielen, S., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr236 · Cited by 3,080
Self-citationDiabetes and Atherosclerosis: Epidemiology, Pathophysiology, and Management
Beckman, J. A., Creager, M. A., & Libby, P. (2002) · JAMA · doi:10.1001/jama.287.19.2570 · Cited by 2,724
Metadata
- Authors
- Roffi, M., Chew, D. P., Mukherjee, D., Bhatt, D. L., White, J. A., Heeschen, C., Hamm, C. W., Moliterno, D. J., Califf, R. M., White, H. D., Kleiman, N. S., Théroux, P., & Topol, E. J.
- Venue
- Circulation
- Published
- 2001-12-04
- Volume
- 104
- Issue
- 23
- Pages
- 2767-2771
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2081799397
- Cited by
- 428
- References
- 27
- FWCI
- 19.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.